Transaction · 0001813798-26-000019

Wassil Jim

Wassil Jim, EVP, CSO, COO, reported an open-market or private sale at Vaxcyte, Inc. involving 1334.000000 shares for an estimated $79401.01. Reported holdings after the transaction were 145435.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEVP, CSO, COO
PCVXVaxcyte, Inc.
Trade date
Sep 09, 2026
Filing date
Sep 09, 2026
View on SEC Insider profile
Estimated value-$79.4kShares × reported price
Shares traded1.33k$59.52 per share
Holdings after145kDirect
% of reported position traded0.91%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 146,769 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

PCVX price since this filing

Daily closing prices, with the filing date and available return windows
PCVX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -2.1%1w ago +5.1%1d ago +1.4%
Returns since7d -1.2%30d +19.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001813798-26-000019
Common Stock
Transaction date
Sep 09, 2026
Filed Sep 09, 2026, 09:46 PM · 0d delay
Shares
1,334 sh
$59.52 per share
Estimated value
-$79.4k
Computed from shares × price
Holdings after
145,435 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Repeat Seller 10b5-1 Detected
Filing-only score

0 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, Chief Scientific Ofc, COO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.

  2. F2

    The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder o…

  3. issuer, full information regarding the number of shares sold at each separate price.

  4. F3

    Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.

  5. F4

    The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder…

Original filing · 0001813798-26-000019
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

PCVX